Administration
glucocorticoids
induces
ocular hypertension
patients
untreated
patients
secondary glaucoma
primary open-angle glaucoma
POAG
pathology
glucocorticoid-induced glaucoma
animal model
murine
model
glucocorticoid-induced glaucoma
glaucoma
features
patients
Treatment
WT mice
topical ocular
dexamethasone
elevation
intraocular pressure
IOP
functional
structural loss
retinal ganglion cells
axonal degeneration
glucocorticoid-induced glaucoma
human
patients
dexamethasone-induced ocular hypertension
associated with
chronic
trabecular meshwork
TM
patients
withdrawal
dexamethasone
treatment
elevated
IOP
ER stress
animal model
Dexamethasone
induced
transcriptional factor
CHOP
marker
chronic ER stress
anterior
tissues
Chop deletion
reduced
ER stress
tissues
dexamethasone-induced ocular hypertension
reduction
ER stress
TM
sodium 4-phenylbutyrate
dexamethasone-induced ocular hypertension
WT mice
data
ER stress
glucocorticoid-induced ocular hypertension
reducing
ER stress
potential
therapeutic strategy
treating
glucocorticoid-induced glaucoma
